Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry

Table 4 Binary logistics regression (effect of polysensitization)

Sample	n	Dependent variable	OR	95% CI for OR		p
Sample	n	Dependent variable	OR	Lower	Upper	p
Whole sample	279	Being a responder	2.217	1.137	4.323	0.02
Whole sample	279	Improvement in ACT (≥ 3 points)	0.503	0.268	0.944	0.032
		Reduction in exacerbations	0.749	0.4	1.401	0.365
		Improvement in FEV1(%pred)	0.567	0.301	1.066	0.078
		Reduction in FeNO	1.155	0.536	2.486	0.713
All patients receiving SCS	201	Reduction in SCS dose	2.048	0.677	6.196	0.205
Responders	161	Improvement in ACT (≥ 3 points)	0.398	0.179	0.883	0.023
		Reduction of exacerbations	0.431	0.198	0.938	0.034
		Improvement in FEV1(%pred)	0.471	0.217	1.019	0.056
		Reduction in FeNO	1.601	0.63	4.072	0.323
All responders receiving SCS	119	Reduction in SCS dose	0.635	0.184	2.179	0.474

ISSN: 1710-1492